BlackRock’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BlackRock’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-65,436	Closed	-$20K	–	5145
2018 Q1	$20K	Sell	65,436 -690	-1%	-$1.03K	﹤0.01%	4568
2017 Q4	$109K	Sell	66,126 -4	-0%	-$7	﹤0.01%	4325
2017 Q3	$95K	Buy	66,130 +2	+0%	+$3	﹤0.01%	4366
2017 Q2	$107K	Sell	66,128 -296,057	-82%	-$664K	﹤0.01%	4390
2017 Q1	$1.23M	Buy	362,185 +361,836	+103,678%	+$1.71M	﹤0.01%	3770
2016 Q4	$2K	Sell	349 -52	-13%	-$900	﹤0.01%	3664
2016 Q3	$10K	Hold	401	–	–	﹤0.01%	3408
2016 Q2	$10K	Buy	401 +77	+24%	+$2.17K	﹤0.01%	3418
2016 Q1	$9K	Buy	324 +216	+200%	+$5.86K	﹤0.01%	3223
2015 Q4	$4K	Sell	108 -575	-84%	-$25.4K	﹤0.01%	3224
2015 Q3	$33K	Buy	683 +575	+532%	+$40.2K	﹤0.01%	2113
2015 Q2	$7K	Buy	+108	New	+$5K	﹤0.01%	3031

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

BlackRock's ANTH Position: Q2 2018 in Review

BlackRock sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 65,436 shares — an estimated $20K sold.

BlackRock first reported a position in ANTH in Q2 2015 and held it in 12 quarters. The position peaked at $1.23M in Q1 2017. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

BlackRock reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
BlackRock sold 65,436 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $20K.
BlackRock first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 12 quarters.
BlackRock's Anthera Pharmaceuticals, Inc. position peaked at $1.23M in Q1 2017.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on BlackRock's 13F filing for Q2 2018, filed 9 Aug 2018.